FDG PET/CT versus Bone Marrow Biopsy for Diagnosis of Bone Marrow Involvement in Non-Hodgkin Lymphoma: A Systematic Review
The management of non-Hodgkin lymphoma (NHL) patients requires the identification of bone marrow involvement (BMI) using a bone marrow biopsy (BMB), as recommended by international guidelines. Multiple studies have shown that [<sup>18</sup>F]FDG positron emission tomography, combined wit...
Main Authors: | Jawaher Almaimani, Charalampos Tsoumpas, Richard Feltbower, Irene Polycarpou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/12/2/540 |
Similar Items
-
The Role of PET/CT to Detect Bone Marrow Involvement in Hodgkin Lymphoma
by: Ali ESER, et al.
Published: (2019-04-01) -
PET/CT and bone marrow biopsy (BMB) in evaluating bone marrow in lymphoma
by: Youstina Elamir, et al.
Published: (2020-10-01) -
Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
by: Güven Çetin, et al.
Published: (2015-07-01) -
Diagnosis and Prognosis of Non-Hodgkin's Lymphoma with Bone Marrow Involvement
by: GAO Fan, et al.
Published: (2018-08-01) -
Bone marrow biopsy in non-Hodgkin lymphoma: A morphological study
by: Kumar Suneet, et al.
Published: (2009-07-01)